Company: MYSEW
Filing Date: 2025-11-26
Form Type: S-3
Source: 0001213900-25-115502
Chunk: 18

Company: Myseum, Inc.
Filing Date: 2025-11-26
Form: S-3
Chunk 18
---
ization of our products, research and development, general and administrative expenses, license or technology acquisitions,
and working capital and capital expenditures. We may also use the net proceeds to invest in or acquire complementary businesses, products,
or technologies, although we have no current commitments or agreements with respect to any such investments or acquisitions as of the
date of this prospectus. We have not determined the amount of net proceeds to be used specifically for the foregoing purposes. As a result,
our management will have broad discretion in the allocation of the net proceeds and investors will be relying on the judgment of our
management regarding the application of the proceeds of any sale of the securities. Pending use of the net proceeds, we intend to invest
the proceeds in short-term, investment-grade, interest-bearing instruments.

Each time we offer securities
under this prospectus, we will describe the intended use of the net proceeds from that offering in the applicable prospectus supplement.
The actual amount of net proceeds we spend on a particular use will depend on many factors, including, our future capital expenditures,
the amount of cash required by our operations, and our future revenue growth, if any. Therefore, we will retain broad discretion in the
use of the net proceeds.

<div align='center'>-8-

DESCRIPTION OF CAPITAL STOCK</div>

General

The following description
of our capital stock, together with any additional information we include in any applicable prospectus supplement or any related free
writing prospectus, summarizes the material terms and provisions of our common stock and the preferred stock that we may offer under
this prospectus. While the terms we have summarized below will apply generally to any future common stock or preferred stock that we
may offer, we will describe the particular terms of any class or series of these securities in more detail in the applicable prospectus
supplement. For the complete terms of our common stock and preferred stock, please refer to our Articles of Incorporation, as amended
(the “Articles of Incorporation”) and our amended and restated bylaws, as amended (the “Bylaws”) that are incorporated
by reference into the registration statement of which this prospectus is a part or may be incorporated by reference in this prospectus
or any applicable prospectus supplement. The terms of these securities may also be affected by the Nevada Revised Statutes. The summary
below and that contained in any applicable prospectus supplement or any related free writing prospectus are qualified in their entirety
by reference to our Articles of Incorporation and our Bylaws.

As of the date